ATM- and ATR-mediated phosphorylation of XRCC3 regulates DNA double-strand break-induced checkpoint activation and repair

Molecular and Cellular Biology

Volumn 33, Issue 9, 2013, Pages 1830-1844

  Somyajit, Kumar ^a   Basavaraju, Shivakumar ^a   Scully, Ralph ^b   Nagaraju, Ganesh ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; PROTEIN; RAD51 PROTEIN; SERINE; UNCLASSIFIED DRUG; XRCC2 PROTEIN; XRCC3 PROTEIN;

ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CHROMATIN; CONTROLLED STUDY; DNA DAMAGE CHECKPOINT; DNA REPAIR; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE; DNA; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DNA-BINDING PROTEINS; HUMANS; INTERPHASE; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SEQUENCE ALIGNMENT; TUMOR SUPPRESSOR PROTEINS;

EID: 84876303107     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01521-12     Document Type: Article

References (51)

1. Ciccia A, Elledge SJ. 2010. The DNA damage response: making it safe to play with knives. Mol. Cell 40:179-204.
2. Jackson SP, Bartek J. 2009. The DNA-damage response in human biology and disease. Nature 461:1071-1078.
3. Kastan MB, Bartek J. 2004. Cell-cycle checkpoints and cancer. Nature 432:316-323.
4. Lavin MF. 2008. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 9:759-769.
5. O'Driscoll M, Jeggo PA. 2006. The role of double-strand break repair-insights from human genetics. Nat. Rev. Genet. 7:45-54.
6. Shiloh Y. 2003. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3:155-168.
7. Cimprich KA, Cortez D. 2008. ATR: an essential regulator of genome integrity. Nat. Rev. Mol. Cell Biol. 9:616-627.
8. Flynn RL, Zou L. 2011. ATR: a master conductor of cellular responses to DNA replication stress. Trends Biochem. Sci. 36:133-140.
9. Lavin MF. 2007. ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene 26:7749-7758.
10. Thompson LH. 2012. Recognition, signaling, and repair of DNA doublestrand breaks produced by ionizing radiation in mammalian cells: the molecular choreography. Mutat. Res. 751:158-246.
11. Traven A, Heierhorst J. 2005. SQ/TQ cluster domains: concentrated ATM/ATR kinase phosphorylation site regions in DNA-damage-response proteins. Bioessays 27:397-407.
12. Somyajit K, Subramanya S, Nagaraju G. 2010. RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer. Carcinogenesis 31:2031-2038.
13. Suwaki N, Klare K, Tarsounas M. 2011. RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis. Semin. Cell Dev. Biol. 22:898-905.
14. Chun J, Buechelmaier ES, Powell SN. 2013. Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway. Mol. Cell. Biol. 33:387-395.
15. Qing Y, Yamazoe M, Hirota K, Dejsuphong D, Sakai W, Yamamoto KN, Bishop DK, Wu X, Takeda S. 2011. The epistatic relationship between BRCA2 and the other RAD51 mediators in homologous recombination.PLoS Genet. 7:e1002148. doi:10.1371/journal.pgen.1002148.
16. Nagaraju G, Hartlerode A, Kwok A, Chandramouly G, Scully R. 2009. XRCC2 and XRCC3 regulate the balance between short-and long-tract gene conversions between sister chromatids. Mol. Cell. Biol. 29:4283-4294.
17. Nagaraju G, Odate S, Xie A, Scully R. 2006. Differential regulation of short-and long-tract gene conversion between sister chromatids by Rad51C. Mol. Cell. Biol. 26:8075-8086.
18. Griffin CS, Simpson PJ, Wilson CR, Thacker J. 2000. Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat. Cell Biol. 2:757-761.
19. Rodrigue A, Coulombe Y, Jacquet K, Gagne JP, Roques C, Gobeil S, Poirier G, Masson JY. 29 October 2012. The RAD51 paralogs ensure cellular protection against mitotic defects and aneuploidy. J. Cell Sci. [Epub ahead of print.] doi:10.1242/jcs.114595.
20. Tarsounas M, Munoz P, Claas A, Smiraldo PG, Pittman DL, Blasco MA, West SC. 2004. Telomere maintenance requires the RAD51D recombination/repair protein. Cell 117:337-347.
21. Compton SA, Choi JH, Cesare AJ, Ozgur S, Griffith JD. 2007. Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells. Cancer Res. 67:1513-1519.
22. Oganesian L, Karlseder J. 2011. Mammalian 5' C-rich telomeric overhangs are a mark of recombination-dependent telomere maintenance. Mol. Cell 42:224-236.
23. Wang RC, Smogorzewska A, de Lange T. 2004. Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119: 355-368.
24. Badie S, Liao C, Thanasoula M, Barber P, Hill MA, Tarsounas M. 2009. RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation. J. Cell Biol. 185:587-600.
25. Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Muller-Myhsok B, Neveling K, Kiechle M, Mathew CG, Schindler D, Schmutzler RK, Hanenberg H. 2010. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat. Genet. 42:410-414.
26. Somyajit K, Subramanya S, Nagaraju G. 2012. Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility. J. Biol. Chem. 287:3366-3380.
27. Vaz F, Hanenberg H, Schuster B, Barker K, Wiek C, Erven V, Neveling K, Endt D, Kesterton I, Autore F, Fraternali F, Freund M, Hartmann L, Grimwade D, Roberts RG, Schaal H, Mohammed S, Rahman N, Schindler D, Mathew CG. 2010. Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat. Genet. 42:406-409.
28. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, III, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ. 2007. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316:1160-1166.
29. Puget N, Knowlton M, Scully R. 2005. Molecular analysis of sister chromatid recombination in mammalian cells. DNA Repair (Amst.) 4:149-161.
30. Lou Z, Minter-Dykhouse K, Wu X, Chen J. 2003. MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature 421:957-961.
31. Wu L, Luo K, Lou Z, Chen J. 2008. MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks. Proc. Natl. Acad. Sci. U. S. A. 105:11200-11205.
32. Gildemeister OS, Sage JM, Knight KL. 2009. Cellular redistribution of Rad51 in response to DNA damage: novel role for Rad51C. J. Biol. Chem. 284:31945-31952.
33. Petermann E, Orta ML, Issaeva N, Schultz N, Helleday T. 2010. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair.Mol. Cell 37:492-502.
34. 2-phase cells. J. Biol. Chem. 279:42313-42320.
35. Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, Jackson SP. 2006. ATM-and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol. 8:37-45.
36. Myers JS, Cortez D. 2006. Rapid activation of ATR by ionizing radiation requires ATM and Mre11. J. Biol. Chem. 281:9346-9350.
37. Petermann E, Helleday T. 2010. Pathways of mammalian replication fork restart. Nat. Rev. Mol. Cell Biol. 11:683-687.
38. Yuan SS, Chang HL, Lee EY. 2003. Ionizing radiation-induced Rad51 nuclear focus formation is cell cycle-regulated and defective in both ATM(-/-) and c-Abl(-/-) cells. Mutat. Res. 525:85-92.
39. Jensen RB, Carreira A, Kowalczykowski SC. 2010. Purified human BRCA2 stimulates RAD51-mediated recombination. Nature 467:678-683.
40. Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J. 2001. The ATMChk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410:842-847.
41. Xu B, Kim S, Kastan MB. 2001. Involvement of BRCA1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 21: 3445-3450.
42. Buscemi G, Savio C, Zannini L, Micciche F, Masnada D, Nakanishi M, Tauchi H, Komatsu K, Mizutani S, Khanna K, Chen P, Concannon P, Chessa L, Delia D. 2001. Chk2 activation dependence on Nbs1 after DNA damage. Mol. Cell. Biol. 21:5214-5222.
43. Esashi F, Christ N, Gannon J, Liu Y, Hunt T, Jasin M, West SC. 2005. CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature 434:598-604.
44. Schlacher K, Christ N, Siaud N, Egashira A, Wu H, Jasin M. 2011. Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell 145:529-542.
45. Schlacher K, Wu H, Jasin M. 2012. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. Cancer Cell 22:106-116.
46. Moldovan GL, D'Andrea AD. 2012. To the rescue: the Fanconi anemia genome stability pathway salvages replication forks. Cancer Cell 22:5-6.
47. Ying S, Hamdy FC, Helleday T. 2012. Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1. Cancer Res. 72:2814-2821.
48. Bussen W, Raynard S, Busygina V, Singh AK, Sung P. 2007. Holliday junction processing activity of the BLM-Topo IIIalpha-BLAP75 complex. J. Biol. Chem. 282:31484-31492.
49. Otsuki M, Seki M, Inoue E, Yoshimura A, Kato G, Yamanouchi S, Kawabe Y, Tada S, Shinohara A, Komura J, Ono T, Takeda S, Ishii Y, Enomoto T. 2007. Functional interactions between BLM and XRCC3 in the cell. J. Cell Biol. 179:53-63.
50. Loveday C, Turnbull C, Ramsay E, Hughes D, Ruark E, Frankum JR, Bowden G, Kalmyrzaev B, Warren-Perry M, Snape K, Adlard JW, Barwell J, Berg J, Brady AF, Brewer C, Brice G, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison PJ, Paterson J, Porteous M, Rogers MT, Shanley S, Walker L, Eccles D, Evans DG, Renwick A, Seal S, Lord CJ, Ashworth A, Reis-Filho JS, Antoniou AC, Rahman N. 2011. Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat. Genet. 43:879-882.
51. Park DJ, Lesueur F, Nguyen-Dumont T, Pertesi M, Odefrey F, Hammet F, Neuhausen SL, John EM, Andrulis IL, Terry MB, Daly M, Buys S, Le Calvez-Kelm F, Lonie A, Pope BJ, Tsimiklis H, Voegele C, Hilbers FM, Hoogerbrugge N, Barroso A, Osorio A, Giles GG, Devilee P, Benitez J, Hopper JL, Tavtigian SV, Goldgar DE, Southey MC. 2012. Rare mutations in XRCC2 increase the risk of breast cancer. Am. J. Hum. Genet. 90:734-739.